Latest

Revvity Joins India’s Fight Against Tuberculosis (TB) by Launching its T-SPOT.TB for Latent TB Screening in the Country

healthcare & pharmaceutical

Revvity Joins India’s Fight Against Tuberculosis (TB) by Launching its T-SPOT.TB for Latent TB Screening in the Country

Revvity, a global company that leverages innovation in Diagnostics and Life Sciences, with a strong presence in India, today announced the country launch of its T-SPOT®.TB test for latent TB screening, at MICROCON in Lucknow. Revvity’s T-SPOT®.TB is the only FDA-approved, commercially available IGRA (interferon gamma release

By Copy Desk